PubRank

Thomas Muster

Author PubWeight™ 18.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol 2002 1.63
2 A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis 2010 1.18
3 Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One 2011 1.14
4 Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One 2009 1.04
5 Pre-clinical safety evaluation of pyrrolidine dithiocarbamate. Basic Clin Pharmacol Toxicol 2010 0.96
6 Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice. J Gen Virol 2009 0.93
7 Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses. Cancer Res 2006 0.92
8 Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1. Vaccine 2011 0.90
9 Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma. Pigment Cell Melanoma Res 2011 0.89
10 Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice. PLoS One 2012 0.89
11 Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame. PLoS One 2012 0.87
12 Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells. Med Microbiol Immunol 2009 0.86
13 Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency. J Virol 2010 0.85
14 Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate. Vaccine 2009 0.84
15 Azidothymidine inhibits melanoma cell growth in vitro and in vivo. Melanoma Res 2008 0.83
16 Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture. J Virol 2011 0.83
17 Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1. Vaccine 2013 0.82
18 Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines. Biotechnol J 2013 0.77
19 Sequence variability of retroviral particles derived from human melanoma cells melanoma-associated retrovirus. Virus Res 2006 0.76
20 Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach. PLoS One 2015 0.75